Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17911 | 576 | 29.2 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
9 | 3 | CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 135847 |
1235 | 2 | INDOLE//BISINDOLYLMETHANES//ELLIPTICINE | 9055 |
17911 | 1 | ELLIPTICINE//OLIVACINE//INTOPLICINE | 576 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ELLIPTICINE | authKW | 2198435 | 13% | 58% | 72 |
2 | OLIVACINE | authKW | 286255 | 2% | 60% | 9 |
3 | INTOPLICINE | authKW | 238549 | 1% | 75% | 6 |
4 | PYRIDOCARBAZOLE | authKW | 238549 | 1% | 75% | 6 |
5 | S 16020 2 | authKW | 212046 | 1% | 100% | 4 |
6 | 1 SUBSTITUTED 6H PYRIDO4 3 BCARBAZOLE | authKW | 159035 | 1% | 100% | 3 |
7 | RP 60475 | authKW | 159035 | 1% | 100% | 3 |
8 | 6H PYRIDO4 3 BCARBAZOLE | authKW | 106023 | 0% | 100% | 2 |
9 | CELIPTIUM | authKW | 106023 | 0% | 100% | 2 |
10 | DUAL TOPOISOMERASES I AND II INHIBITORS | authKW | 106023 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 1079 | 13% | 0% | 77 |
2 | Pharmacology & Pharmacy | 987 | 26% | 0% | 148 |
3 | Oncology | 808 | 21% | 0% | 120 |
4 | Chemistry, Organic | 273 | 11% | 0% | 65 |
5 | Toxicology | 236 | 7% | 0% | 39 |
6 | Biochemistry & Molecular Biology | 178 | 19% | 0% | 107 |
7 | Biophysics | 126 | 6% | 0% | 37 |
8 | Crystallography | 119 | 5% | 0% | 26 |
9 | Chemistry, Multidisciplinary | 76 | 10% | 0% | 60 |
10 | Chemistry, Analytical | 15 | 4% | 0% | 22 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NIHR HLTH PROTECT UNIT HLTH IMPACT ENVIRONM H | 95418 | 1% | 60% | 3 |
2 | PHYSIOL CELLULAIRE MOLEC CNRS URA 1180 | 70681 | 0% | 67% | 2 |
3 | ANALYT ENVIRONM SCI | 67444 | 2% | 9% | 14 |
4 | 1 RUE GUY DE LA BROSSE | 53012 | 0% | 100% | 1 |
5 | CEA DSM DRECAM SCM CNRS URA 331 | 53012 | 0% | 100% | 1 |
6 | CHIM PHYS CNRS URA 400 45 RUE ST PE | 53012 | 0% | 100% | 1 |
7 | CNRSINC3MEA 4258FR 3038 | 53012 | 0% | 100% | 1 |
8 | CQO | 53012 | 0% | 100% | 1 |
9 | CRLCC FRANCOIS BACLESSECJF INSERM 96 03 | 53012 | 0% | 100% | 1 |
10 | CRLCC FRANCOIS BACLESSEUP EA 1772 | 53012 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTI-CANCER DRUG DESIGN | 10209 | 2% | 2% | 11 |
2 | NEUROENDOCRINOLOGY LETTERS | 5357 | 3% | 1% | 17 |
3 | BIOMEDICINE & PHARMACOTHERAPY | 1908 | 2% | 0% | 12 |
4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1789 | 1% | 0% | 8 |
5 | INVESTIGATIONAL NEW DRUGS | 1668 | 2% | 0% | 9 |
6 | BIOCHEMICAL PHARMACOLOGY | 1487 | 4% | 0% | 23 |
7 | CRYSTAL STRUCTURE COMMUNICATIONS | 1192 | 1% | 1% | 4 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 1165 | 4% | 0% | 22 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 706 | 2% | 0% | 10 |
10 | JOURNAL DE PHARMACOLOGIE | 629 | 0% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ELLIPTICINE | 2198435 | 13% | 58% | 72 | Search ELLIPTICINE | Search ELLIPTICINE |
2 | OLIVACINE | 286255 | 2% | 60% | 9 | Search OLIVACINE | Search OLIVACINE |
3 | INTOPLICINE | 238549 | 1% | 75% | 6 | Search INTOPLICINE | Search INTOPLICINE |
4 | PYRIDOCARBAZOLE | 238549 | 1% | 75% | 6 | Search PYRIDOCARBAZOLE | Search PYRIDOCARBAZOLE |
5 | S 16020 2 | 212046 | 1% | 100% | 4 | Search S+16020+2 | Search S+16020+2 |
6 | 1 SUBSTITUTED 6H PYRIDO4 3 BCARBAZOLE | 159035 | 1% | 100% | 3 | Search 1+SUBSTITUTED+6H+PYRIDO4+3+BCARBAZOLE | Search 1+SUBSTITUTED+6H+PYRIDO4+3+BCARBAZOLE |
7 | RP 60475 | 159035 | 1% | 100% | 3 | Search RP+60475 | Search RP+60475 |
8 | 6H PYRIDO4 3 BCARBAZOLE | 106023 | 0% | 100% | 2 | Search 6H+PYRIDO4+3+BCARBAZOLE | Search 6H+PYRIDO4+3+BCARBAZOLE |
9 | CELIPTIUM | 106023 | 0% | 100% | 2 | Search CELIPTIUM | Search CELIPTIUM |
10 | DUAL TOPOISOMERASES I AND II INHIBITORS | 106023 | 0% | 100% | 2 | Search DUAL+TOPOISOMERASES+I+AND+II+INHIBITORS | Search DUAL+TOPOISOMERASES+I+AND+II+INHIBITORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FREI, E , STIBOROVA, M , (2014) ELLIPTICINES AS DNA-TARGETED CHEMOTHERAPEUTICS.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 5. P. 575 -591 | 74 | 49% | 12 |
2 | RYVOLOVA, M , ADAM, V , ECKSCHLAGER, T , STIBOROVA, M , KIZEK, R , (2012) STUDY OF DNA-ELLIPTICINE INTERACTION BY CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION.ELECTROPHORESIS. VOL. 33. ISSUE 11. P. 1545-1549 | 32 | 86% | 9 |
3 | STIBOROVA, M , RUPERTOVA, M , FREI, E , (2011) CYTOCHROME P450-AND PEROXIDASE-MEDIATED OXIDATION OF ANTICANCER ALKALOID ELLIPTICINE DICTATES ITS ANTI-TUMOR EFFICIENCY.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1814. ISSUE 1. P. 175-185 | 49 | 49% | 45 |
4 | STIBOROVA, M , CERNA, V , MOSEROVA, M , MRIZOVA, I , ARLT, VM , FREI, E , (2015) THE ANTICANCER DRUG ELLIPTICINE ACTIVATED WITH CYTOCHROME P450 MEDIATES DNA DAMAGE DETERMINING ITS PHARMACOLOGICAL EFFICIENCIES: STUDIES WITH RATS, HEPATIC CYTOCHROME P450 REDUCTASE NULL (HRN (TM)) MICE AND PURE ENZYMES.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 16. ISSUE 1. P. 284 -306 | 47 | 53% | 0 |
5 | STIBOROVA, M , MANHARTOVA, Z , HODEK, P , ADAM, V , KIZEK, R , ECKSCHLAGER, T , FREI, E , (2015) CYTOTOXICITY OF AND DNA ADDUCT FORMATION BY ELLIPTICINE AND ITS MICELLAR FORM IN HUMAN LEUKEMIA CELLS IN VITRO.NEUROENDOCRINOLOGY LETTERS. VOL. 36. ISSUE . P. 22 -28 | 25 | 93% | 0 |
6 | STIBOROVA, M , POLJAKOVA, J , MRIZOVA, I , BOREK-DOHALSKA, L , ECKSCHLAGER, T , ADAM, V , KIZEK, R , FREI, E , (2014) EXPRESSION LEVELS OF ENZYMES METABOLIZING AN ANTICANCER DRUG ELLIPTICINE DETERMINED BY ELECTROMIGRATION ASSAYS INFLUENCE ITS CYTOTOXICITY TO CANCER CELLS - A COMPARATIVE STUDY.INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE. VOL. 9. ISSUE 10. P. 5675 -5689 | 28 | 80% | 1 |
7 | MARTINKOVA, E , DONTENWILL, M , FREI, E , STIBOROVA, M , (2009) CYTOTOXICITY OF AND DNA ADDUCT FORMATION BY ELLIPTICINE IN HUMAN U87MG GLIOBLASTOMA CANCER CELLS.NEUROENDOCRINOLOGY LETTERS. VOL. 30. ISSUE . P. 60 -66 | 29 | 74% | 9 |
8 | STIBOROVA, M , CERNA, V , MOSEROVA, M , ARLT, VM , FREI, E , (2013) THE EFFECT OF BENZO[A]PYRENE ON METABOLIC ACTIVATION OF ANTICANCER DRUG ELLIPTICINE IN MICE.NEUROENDOCRINOLOGY LETTERS. VOL. 34. ISSUE . P. 43-54 | 30 | 59% | 0 |
9 | POLJAKOVA, J , ECKSCHLAGER, T , CINATL, J , KIZEK, R , FREI, E , STIBOROVA, M , (2013) ELECTROCHEMICAL DETERMINATION OF ENZYMES METABOLIZING ELLIPTICINE IN THYROID CANCER CELLS - A TOOL TO EXPLAIN THE MECHANISM OF ELLIPTICINE TOXICITY TO THESE CELLS.INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE. VOL. 8. ISSUE 2. P. 1573-1585 | 22 | 76% | 2 |
10 | STIBOROVA, M , MANHARTOVA, Z , HODEK, P , ADAM, V , KIZEK, R , FREI, E , (2014) FORMATION OF DNA ADDUCTS BY ELLIPTICINE AND ITS MICELLAR FORM IN RATS - A COMPARATIVE STUDY.SENSORS. VOL. 14. ISSUE 12. P. 22982 -22997 | 27 | 55% | 1 |
Classes with closest relation at Level 1 |